Calpine (CPN) Position Lifted by Marshall Wace Llp; Penn Davis Mcfarland Lifted Celgene (CELG) Holding by $10.58 Million as Market Value Declined

April 17, 2018 - By Marguerite Chambers

Celgene Corporation (NASDAQ:CELG) Logo

Penn Davis Mcfarland Inc increased its stake in Celgene Corporation (CELG) by 149.89% based on its latest 2017Q4 regulatory filing with the SEC. Penn Davis Mcfarland Inc bought 101,686 shares as the company’s stock declined 19.30% with the market. The institutional investor held 169,526 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $17.69 million, up from 67,840 at the end of the previous reported quarter. Penn Davis Mcfarland Inc who had been investing in Celgene Corporation for a number of months, seems to be bullish on the $68.10 billion market cap company. The stock increased 1.28% or $1.14 during the last trading session, reaching $90.54. About 3.60 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 17, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Paul Marshall increased its stake in Calpine Corp (CPN) by 382.51% based on its latest 2017Q4 regulatory filing with the SEC. Marshall Wace Llp bought 1.66 million shares as the company’s stock 0.00% . The hedge fund run by Paul Marshall held 2.10 million shares of the central company at the end of 2017Q4, valued at $31.72 million, up from 434,516 at the end of the previous reported quarter. Marshall Wace Llp who had been investing in Calpine Corp for a number of months, seems to be bullish on the $5.50 billion market cap company. It closed at $15.25 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Since December 12, 2017, it had 0 insider buys, and 2 selling transactions for $3.26 million activity. Shares for $577,624 were sold by Hill Thad.

Investors sentiment decreased to 0.85 in 2017 Q4. Its down 0.10, from 0.95 in 2017Q3. It fall, as 36 investors sold CPN shares while 78 reduced holdings. 33 funds opened positions while 64 raised stakes. 238.57 million shares or 12.55% less from 272.79 million shares in 2017Q3 were reported. D E Shaw & stated it has 0% in Calpine Corporation (NYSE:CPN). Menta Ltd Llc stated it has 101,149 shares or 0.3% of all its holdings. Moreover, Profund Ltd Liability Co has 0.02% invested in Calpine Corporation (NYSE:CPN). P Schoenfeld Asset Mngmt Lp has invested 2.03% in Calpine Corporation (NYSE:CPN). 168,748 are owned by First Trust Advisors Lp. Gideon Capital Advsrs holds 0.31% of its portfolio in Calpine Corporation (NYSE:CPN) for 23,046 shares. Walleye Trading Ltd Llc holds 473,536 shares. Prelude Cap Mngmt Ltd Liability invested in 0.93% or 762,276 shares. Macquarie Group holds 4,200 shares or 0% of its portfolio. State Of Wisconsin Investment Board invested 0.07% of its portfolio in Calpine Corporation (NYSE:CPN). Cheyne Capital Management (Uk) Llp holds 7.26% of its portfolio in Calpine Corporation (NYSE:CPN) for 1.10 million shares. Private Management Gru Inc has 1.24 million shares for 0.96% of their portfolio. Havens Advsrs Lc invested in 863,400 shares. Parametric Port Limited Liability Corp invested in 0.02% or 1.39M shares. New York-based Quantbot Technologies Limited Partnership has invested 0.05% in Calpine Corporation (NYSE:CPN).

Among 15 analysts covering Calpine Corporation (NYSE:CPN), 5 have Buy rating, 0 Sell and 10 Hold. Therefore 33% are positive. Calpine Corporation had 44 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, July 10 the stock rating was downgraded by Goldman Sachs to “Neutral”. The company was initiated on Friday, September 18 by Citigroup. The stock of Calpine Corporation (NYSE:CPN) earned “Outperform” rating by BMO Capital Markets on Monday, July 31. UBS maintained it with “Buy” rating and $16 target in Thursday, October 6 report. The stock of Calpine Corporation (NYSE:CPN) earned “Neutral” rating by SunTrust on Monday, March 7. The firm has “Hold” rating by Guggenheim given on Tuesday, March 13. RBC Capital Markets maintained Calpine Corporation (NYSE:CPN) rating on Monday, August 3. RBC Capital Markets has “Outperform” rating and $23 target. The stock of Calpine Corporation (NYSE:CPN) earned “Neutral” rating by UBS on Wednesday, November 2. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Monday, February 6 report. As per Friday, July 31, the company rating was upgraded by Evercore.

Marshall Wace Llp, which manages about $2.38B US Long portfolio, decreased its stake in Rowan Companie (NYSE:RDC) by 24,276 shares to 35,435 shares, valued at $555,000 in 2017Q4, according to the filing. It also reduced its holding in Csx Corp (NYSE:CSX) by 105,866 shares in the quarter, leaving it with 13,744 shares, and cut its stake in Bhp Billiton Adr (Of Blt Ln) (NYSE:BBL).

Since February 8, 2018, it had 1 insider purchase, and 3 sales for $3.58 million activity. The insider LOUGHLIN JAMES J sold 9,250 shares worth $851,093. KAPLAN GILLA had sold 18,500 shares worth $1.77 million on Thursday, February 15. MARIO ERNEST also sold $1.26M worth of Celgene Corporation (NASDAQ:CELG) on Friday, February 23.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, September 29 by Citigroup. The firm has “Buy” rating given on Friday, July 24 by UBS. As per Wednesday, June 14, the company rating was maintained by Oppenheimer. On Monday, October 16 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm has “Outperform” rating by BMO Capital Markets given on Friday, November 17. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, July 6 report. Morgan Stanley downgraded the shares of CELG in report on Thursday, October 5 to “Underweight” rating. The stock of Celgene Corporation (NASDAQ:CELG) has “Mkt Outperform” rating given on Friday, July 24 by JMP Securities. Standpoint Research downgraded Celgene Corporation (NASDAQ:CELG) on Wednesday, November 9 to “Hold” rating. The rating was maintained by Mizuho on Wednesday, July 26 with “Buy”.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It dived, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Beaumont Finance Partners Ltd Liability has invested 0.14% in Celgene Corporation (NASDAQ:CELG). Warren Averett Asset Mngmt Ltd Liability stated it has 0.09% in Celgene Corporation (NASDAQ:CELG). Btg Pactual Glob Asset reported 10,557 shares. B T Mgmt Dba Alpha Mgmt holds 0.52% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 10,635 shares. First Long Island Investors Limited Liability Co holds 126,543 shares or 1.8% of its portfolio. Amer Century Companies accumulated 4.07M shares. Toth Finance Advisory Corporation accumulated 0.01% or 485 shares. Cohen Klingenstein Ltd Company has 13,240 shares. Martin Currie Ltd reported 0.41% stake. 3,144 were reported by Mckinley Carter Wealth Services. Bessemer Grp invested 0.01% of its portfolio in Celgene Corporation (NASDAQ:CELG). F&V Capital Mngmt Ltd Liability Co has 0.37% invested in Celgene Corporation (NASDAQ:CELG). Thrivent Financial For Lutherans accumulated 0.57% or 1.64M shares. Waldron Lp has invested 0.09% of its portfolio in Celgene Corporation (NASDAQ:CELG). Epoch Investment Inc holds 0.03% or 76,608 shares in its portfolio.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: